Multicenter Trial of Hemodilution in Ischemic Stroke "SSS"
Completed
Phase 3 ResultsEligibility Criteria
Inclusion Criteria
Focal neurological deficits of presumed vascular origin with acute onset and persisting at the start of treatment. Treatment started within 48 hours of onset of symptoms.Exclusion Criteria
Cerebral hemorrhage as determined by acute CT scan or lumbar puncture, recent myocardial infarction (within previous 4 weeks), severe angina pectoris and overt signs of left ventricular failure, ongoing anticoagulant treatment, excessively high blood pressure, renal failure, coma, concomitant terminal or life-threatening disorders, severe preexisting handicaps which might interfere with accurate neurological scoring.Recruitment
- Gender: Both
- Study Size: 370
- Number of Centers: 15
- Max Time from Onset: 48 Hours
- Follow Up: 3 Months
Principal Investigator
-
Kjell Asplund
Department of Medicine Umea University Hospital Sweden.
Locations
- Norway, Sweden, Finland, Denmark